American Century Companies’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-43,642
| Closed | -$363K | – | 1627 |
|
|
2019
Q4 | $363K | Sell |
43,642
-78,930
| -64% | -$657K | ﹤0.01% | 1251 |
|
|
2019
Q3 | $905K | Buy |
+122,572
| New | +$905K | ﹤0.01% | 1034 |
|
|
2018
Q4 | – | Sell |
-156,248
| Closed | -$2.89M | – | 1257 |
|
|
2018
Q3 | $2.89M | Buy |
156,248
+931
| +0.6% | +$17.2K | ﹤0.01% | 963 |
|
|
2018
Q2 | $3.55M | Sell |
155,317
-49,743
| -24% | -$1.14M | ﹤0.01% | 911 |
|
|
2018
Q1 | $5.83M | Sell |
205,060
-102,758
| -33% | -$2.92M | 0.01% | 793 |
|
|
2017
Q4 | $6.5M | Buy |
307,818
+138,019
| +81% | +$2.91M | 0.01% | 790 |
|
|
2017
Q3 | $3.09M | Buy |
169,799
+110,283
| +185% | +$2M | ﹤0.01% | 959 |
|
|
2017
Q2 | $922K | Buy |
+59,516
| New | +$922K | ﹤0.01% | 1151 |
|